{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:37:07Z","timestamp":1787585827590,"version":"build-2736575974"},"reference-count":25,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRP-2023-1560"],"award-info":[{"award-number":["IIRP-2023-1560"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"award":["IIRP-2023-1560"],"award-info":[{"award-number":["IIRP-2023-1560"]}],"id":[{"id":"https:\/\/ror.org\/0492wrx28","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Methods Protoc.","MPs"],"abstract":"<jats:p>Cell-free DNA (cfDNA) has emerged as a promising liquid biopsy biomarker; however, differences in analytical methods may influence cfDNA quantification and integrity assessment. This study compared plasma cfDNA concentration and integrity between treatment-na\u00efve breast cancer (BC) patients (n = 100) and healthy controls (HC; n = 70) using complementary analytical platforms. cfDNA concentration was measured by Qubit fluorometry, TapeStation (TS) electrophoretic profiling, and ALU-based quantitative PCR (qPCR). An exploratory genomic DNA (gDNA) correction of Qubit-derived cfDNA concentration was performed using TS-derived fragment-size information. cfDNA integrity was assessed using the ALU-derived DNA Integrity Index (DII (ALU); ALU247\/ALU115) and the TS-derived DNA Integrity Index (DII (TS)), and methods were compared for their correlation and agreement. Qubit- and TS-based cfDNA measurements were significantly higher in BC patients than in HC. Among the ALU-based qPCR measures, although ALU115 did not differ significantly between groups, ALU247 and DII (ALU) were significantly higher in BC patients, indicating an enrichment of longer cfDNA fragments. Exploratory gDNA correction did not substantially alter the observed differences. Significant positive correlations were observed among the cfDNA quantification methods. Supporting these findings, agreement analysis demonstrated improved agreement following gDNA correction. In contrast, cfDNA integrity assessment was method-dependent: although DII (ALU) was significantly higher in BC patients, DII (TS) did not differ significantly between groups, and no significant correlation or agreement was observed between the two indices, indicating that the two methods evaluate different lengths of cfDNA fragments. These findings demonstrate that complementary analytical platforms consistently differentiated BC patients from HC based on cfDNA concentration, whereas cfDNA integrity assessment depended on the analytical method employed. Together, these findings provide methodological insights into cfDNA quantification and fragmentation assessment and support the complementary use of fluorometric, electrophoretic, and ALU-based qPCR approaches for comprehensive cfDNA characterization.<\/jats:p>","DOI":"10.3390\/mps9050124","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:49:34Z","timestamp":1787582974000},"page":"124","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating Cell-Free DNA Quantification and Integrity in Breast Cancer Using Fluorometric, Electrophoretic and PCR-Based Platforms"],"prefix":"10.3390","volume":"9","author":[{"given":"Gisha Rose","family":"Antony","sequence":"first","affiliation":[{"name":"Division of Molecular Medicine, St. John\u2019s Research Institute (SJRI), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya P.","family":"Nimbalkar","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, St. John\u2019s Research Institute (SJRI), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sowmya","family":"Nagaraj","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, St. John\u2019s Research Institute (SJRI), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahalakshmi","family":"Subramanya","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, St. John\u2019s Research Institute (SJRI), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama C.","family":"Eshwara Rao","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, St. John\u2019s Research Institute (SJRI), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganapathi","family":"Bantwal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, St John\u2019s National Academy of Health Sciences (SJMCH), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-8347","authenticated-orcid":false,"given":"Belinda","family":"George","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, St John\u2019s National Academy of Health Sciences (SJMCH), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Ajoy","sequence":"additional","affiliation":[{"name":"St. John\u2019s Medical College (SJMC), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal M.","family":"Ahamed","sequence":"additional","affiliation":[{"name":"St. John\u2019s Medical College (SJMC), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh S.","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, St John\u2019s National Academy of Health Sciences (SJMCH), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothi D.","family":"N","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, St. John\u2019s Medical College (SJMC), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya Kumari","family":"S","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, St. John\u2019s Medical College (SJMC), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2269-3704","authenticated-orcid":false,"given":"Jyothi S.","family":"Prabhu","sequence":"additional","affiliation":[{"name":"Division of Molecular Medicine, St. John\u2019s Research Institute (SJRI), Bangalore 560034, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Qin, Z., Ljubimov, V.A., Zhou, C., Tong, Y., and Liang, J. (2016). Cell-free circulating tumor DNA in cancer. Chin. J. Cancer, 35.","DOI":"10.1186\/s40880-016-0092-4"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ccell.2025.09.006","article-title":"Cell-free DNA fragmentomics in cancer","volume":"43","author":"Tsui","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/s41591-025-04093-9","article-title":"Liquid biopsies across the cancer care continuum","volume":"31","author":"Landon","year":"2025","journal-title":"Nat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sobhani, N., Generali, D., Zanconati, F., Bortul, M., and Scaggiante, B. (2018). Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives?. World J. Clin. Oncol., 9.","DOI":"10.5306\/wjco.v9.i2.26"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-014-2946-2","article-title":"Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis","volume":"146","author":"Madhavan","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2006.05.9493","article-title":"Prediction of breast tumor progression by integrity of free circulating DNA in serum","volume":"24","author":"Umetani","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1158\/1078-0432.CCR-19-3005","article-title":"Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer","volume":"26","author":"Parsons","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhu, G., Guo, Y.A., Ho, D., Poon, P., Poh, Z.W., Wong, P.M., Gan, A., Chang, M.M., Kleftogiannis, D., and Lau, Y.T. (2021). Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden. Nat. Commun., 12.","DOI":"10.1038\/s41467-021-22463-y"},{"key":"ref_10","first-page":"1","article-title":"Impact of early changes in circulating cell-free DNA load on outcome in metastatic luminal breast cancer patients","volume":"12","author":"Abdelhalim","year":"2025","journal-title":"Senses Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lamminaho, M., Kujala, J., Peltonen, H., Tengstr\u00f6m, M., Kosma, V.M., and Mannermaa, A. (2021). High cell-free DNA integrity is associated with poor breast cancer survival. Cancers, 13.","DOI":"10.3390\/cancers13184679"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Iwai, T., Yamada, T., Uehara, K., Shinji, S., Matsuda, A., Yokoyama, Y., Takahashi, G., Miyasaka, T., Kanaka, S., and Koizumi, M. (2025). Evaluating cell-free DNA integrity index as a non-invasive biomarker for neoadjuvant chemotherapy in colorectal cancer patients. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14570-6"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15263\/jlmqa.2019.41.4.214","article-title":"Quantification of cell-free DNA: A comparative study of three different methods","volume":"41","author":"Jeon","year":"2019","journal-title":"J. Lab Med. Qual. Assur."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sinha, S.K., Brown, H., Knopf, K., Hall, P., Shannon, W.D., and Haack, W. (2025). A novel cell-free DNA fragmentomic assay and its application for monitoring disease progression in real time for stage IV cancer patients. Cancers, 17.","DOI":"10.20944\/preprints202508.0913.v1"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Nair, M.G., Ramesh, R.S., Naidu, C.M., Mavatkar, A.D., Vp, S., Ramamurthy, V., Somashekaraiah, V.M., CE, A., Raghunathan, K., and Panigrahi, A. (2023). Estimation of ALU repetitive elements in plasma as a cost-effective liquid biopsy tool for disease prognosis in breast cancer. Cancers, 15.","DOI":"10.3390\/cancers15041054"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Alcaide, M., Cheung, M., Hillman, J., Rassekh, S.R., Deyell, R.J., Batist, G., Karsan, A., Wyatt, A.W., Johnson, N., and Scott, D.W. (2020). Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-69432-x"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Khurram, I., Khan, M.U., Ibrahim, S., Saleem, A., Khan, Z., Mubeen, M., Khawar, A., and Ali, Q. (2023). Efficacy of cell-free DNA as a diagnostic biomarker in breast cancer patients. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-42726-6"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Spindler, K.L.G., Pallisgaard, N., Andersen, R.F., Brandslund, I., and Jakobsen, A. (2015). Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0108247"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.10.029","article-title":"Plasma total cell-free DNA is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients","volume":"88","author":"Valpione","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1158\/1078-0432.CCR-19-3015","article-title":"Harmonizing cell-free DNA collection and processing practices through evidence-based guidance","volume":"26","author":"Greytak","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s12010-018-2858-4","article-title":"Plasma ALU-247, ALU-115, and cfDNA integrity as diagnostic and prognostic biomarkers for breast cancer","volume":"187","author":"Hussein","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jnci.2016.08.003","article-title":"Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequence","volume":"28","author":"Fawzy","year":"2016","journal-title":"J. Egypt Natl. Cancer Inst."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clinbiochem.2021.04.021","article-title":"Alu cell-free DNA concentration, Alu index, and LINE-1 hypomethylation as a cancer predictor","volume":"94","author":"Park","year":"2021","journal-title":"Clin. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"E1317","DOI":"10.1073\/pnas.1500076112","article-title":"Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients","volume":"112","author":"Jiang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Mouliere, F., Chandrananda, D., Piskorz, A.M., Moore, E.K., Morris, J., Ahlborn, L.B., Mair, R., Goranova, T., Marass, F., and Heider, K. (2018). Enhanced detection of circulating tumor DNA by fragment size analysis. Sci. Transl. Med., 10.","DOI":"10.1126\/scitranslmed.aat4921"}],"container-title":["Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-9279\/9\/5\/124\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:15:30Z","timestamp":1787584530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-9279\/9\/5\/124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["mps9050124"],"URL":"https:\/\/doi.org\/10.3390\/mps9050124","relation":{},"ISSN":["2409-9279"],"issn-type":[{"value":"2409-9279","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}